May/June 2018 Catalogue
Total Page:16
File Type:pdf, Size:1020Kb

Load more
Recommended publications
-
CST-On-Demand-Binder.Pdf
Zander Perioperative Education Zander CST Exam Preparation Course Zander Perioperative Education Certification Preparation for CNOR, CAPA-CPAN, CST and CBSPD Wendy Zander MSN/Ed, RN, CNOR [email protected] Test Taking Strategies Objectives: 1. Apply Test Taking Strategies for the CST exam 2. Create a Personal Study Plan 3. Eligibility • Registering for the exam • Exam Format • Time Management • Test Taking Strategies Eligibility • Current or previously Certified Surgical Technologist (CST) ▫ Evidence of CST Certification • Graduate of a surgical technology program accredited by CAAHEP ▫ Evidence of proof of graduation • Graduate of a surgical technology accredited by ABHES ▫ Evidence of proof of graduation www.periop-ed.com 1 Zander Perioperative Education Military Eligible • A graduate of a military training program in surgical technology is always eligible whether it was before, during or after having CAAHEP accreditation. ▫ a copy of your DD214 (must state location of the base where program was completed), ▫ a copy of your graduation certificate from the surgical technology training program ▫ a smart transcript Accelerated Alternate Delivery (AAD) Pathway • Have on-the-job training in surgical technology • Are a graduate from a surgical technology program that did not hold CAAHEP accreditation during your enrollment CST Testing Fees First Time Test Takers Exam Fee (AST Members) Exam Fee (Non Members) $190 $290 Current or Previous Certified Surgical Technologist Renewing First Time Test Takers Certification by Examination Exam Fee -
B.J.ZH.F.Panther Medical Equipment Co., Ltd. 北京派爾特醫療科技股份
The Stock Exchange of Hong Kong Limited and the Securities and Futures Commission take no responsibility for the contents of this Application Proof, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this Application Proof. Application Proof of B.J.ZH.F.Panther Medical Equipment Co., Ltd. 北京派爾特醫療科技股份有限公司 (the “Company”) (a joint stock company incorporated in the People’s Republic of China with limited liability) WARNING The publication of this Application Proof is required by The Stock Exchange of Hong Kong Limited (the “Stock Exchange”) and the Securities and Futures Commission (the “Commission”) solely for the purpose of providing information to the public in Hong Kong. This Application Proof is in draft form. The information contained in it is incomplete and is subject to change which can be material. By viewing this document, you acknowledge, accept and agree with the Company, its sole sponsor, advisors or members of the underwriting syndicate that: (a) this document is only for the purpose of providing information about the Company to the public in Hong Kong and not for any other purposes. No investment decision should be based on the information contained in this document; (b) the publication of this document or supplemental, revised or replacement pages on the Stock Exchange’s website does not give rise to any obligation of the Company, its sole sponsor, advisors or members of the underwriting syndicate to proceed with an offering in Hong Kong or any other jurisdiction. -
Minimal Endoscope-Assisted Thyroidectomy Through a Retroauricular Approach: an Evolving Solo Surgery Technique
ORIGINAL ARTICLE Minimal Endoscope-assisted Thyroidectomy Through a Retroauricular Approach: An Evolving Solo Surgery Technique Myung Jin Ban, MD,*w Jae Won Chang, MD,z Won Shik Kim, MD,y Hyung Kwon Byeon, MD, PhD,y Yoon Woo Koh, MD, PhD,y and Jae Hong Park, MD, PhD* (RA), or transoral approach.1–5 Endoscopic thyroidectomy Abstract: This study aimed to evaluate the feasibility and efficacy of through an RA approach is an especially excellent choice minimal endoscope-assisted thyroidectomy (MEAT) through a for head and neck surgeons because of their familiarity with retroauricular (RA) approach. Most of the thyroidectomy oper- the direction of the approach, the short distance to the ative time was accounted for by direct visualization through the thyroid gland, and a good cosmetic outcome without the RA window, minimizing interference between surgical instruments. 6 Endoscope use was minimized and limited to critical surgical need for additional incisions. aspects, including preservation of the recurrent laryngeal nerve and Despite the advantages of the RA approach, funda- parathyroid glands. The recurrent laryngeal nerve was neuro- mental limitations of endoscopic surgery still exist, includ- monitored throughout the procedure. MEAT through an RA ing a narrow operative field that restricts the free movement approach was performed in 8 patients with papillary thyroid car- of instruments. Gas insufflation, an additional incision for cinoma (mean tumor size, 1.2 ± 0.5 cm). The mean patient age was the endoscope port, robotic arm assistance, and a flexible 41.1 ± 7.5 years. The endoscopic operating time was endoscope holder for solo surgery have all been used to 19 ± 3.4 minutes, and no postoperative hematoma, seroma, or overcome this limitation.3,7,8 vocal cord paralysis was observed. -
Snakes, Worms and Catheters: Continuum and Serpentine Robots for Minimally Invasive Surgery
IEEE ICRA 2010 Full Day Workshop Snakes, Worms and Catheters: Continuum and Serpentine Robots for Minimally Invasive Surgery Monday May 3, 2010 Anchorage, Alaska USA Organizers: Pierre E. Dupont Mohsen Mahvash Workshop Contents 1- Introduction 2- Abstract of Invited Talks • Neal Tanner, Hansen Medical (commercialization) 3 • David Camarillo, Hansen Medical (robotic catheters) 5 • Howie Choset, Carnegie Mellon University (snakes) 6 • Pierre Dupont, Children’s Hospital Boston, HMS (continuum robots) 8 • Koji Ikuta, Nagoya University (robotic catheters) 9 • Joseph Madsen, MD, Children’s Hospital, Harvard Med (clinical perspective) 11 • Mohsen Mahvash, Children’s Hospital Boston, HMS (continuum robots) 12 • Rajni Patel, University of Western Ontario (robotic catheters) 14 • Cameron Riviere, Carnegie Mellon University (worm robots) 16 • Nabil Simaan, Columbia University (NOTES) 17 • Russell Taylor, Johns Hopkins University (snake robots) 19 • Robert Webster, Vanderbilt University (continuum robots) 20 • Guang-Zhong Yang, Imperial College (snake robots) 23 3- Short Papers • A Highly Articulated Robotic System (CardioARM) is Safer than a Rigid System for Intrapericardial Intervention in a Porcine Model 24 • Towards a Minimally Invasive Neurosurgical Intracranial Robot 27 • Uncertainty Analysis in Continuum Robot Kinematics 30 • Ultrasound Image-Controlled Robotic Cardiac Catheter System 33 • Steerable Continuum Robot Design for Cochlear Implant Surgery 36 • Modular Needle Steering Driver for MRI-guided Transperineal Prostate Intervention 39 -
Keyword Index to Assist Manufacturers in Verifying the Class of Medical Devices
September 12, 2006 NOTICE Our file number: 06-120629-368 Re: Keyword Index to Assist Manufacturers in Verifying the Class of Medical Devices Health Canada is pleased to announce the release of the revised Keyword Index to Assist Manufacturers in Verifying the Class of Medical Devices. This guidance document supersedes the January 14, 2000 version of the same document. The Keyword Index to Assist Manufacturers in Verifying the Class of Medical Devices is intended to assist manufacturers in confirming the classification of medical device products after application of the Classification Rules for Medical Devices set out in Schedule 1 of the Medical Devices Regulations. This guidance document has been revised to reflect changes to the risk- based classification of particular medical device groups. Specifically, the following major changes have been made to the document: • the reclassification of specific medical device groups; • the removal of redundant information; • the addition of medical device groups; and • the omission of product groups that do not fit the meaning of a medical device as defined in the Food and Drugs Act. To search for a medical device group within the Keyword Index to Assist Manufacturers in Verifying the Class of Medical Devices PDF file, go to Edit/Find and enter a keyword, preferred name code or description in the “Find” field. For instance, to verify the risk-based classification of dental burs, enter “bur” or “drill” in the “Find” field. Please note that this guidance document is provided only as a guide and that in the event of any discrepancy between this document and the Classification Rules for Medical Devices described in the Medical Devices Regulations, the latter shall prevail. -
Rapid HTA Report Ultrasonic Energy Devices for Surgery July 2014
Rapid HTA report 1 Ultrasonic energy devices for surgery July 2014 1 This report should be cited as: Migliore A, Corio M, Perrini MR, Rivoiro C, Jefferson T. Ultrasonic energy devices for surgery: rapid HTA report. Agenas, Agenzia nazionale per i servizi sanitari regionali. Rome, July 2014. Contributions Authors Antonio Migliore, Mirella Corio, Maria Rosaria Perrini, Chiara Rivoiro, and Tom Jefferson Agenas, Agenzia nazionale per i servizi sanitari regionali, Area Funzionale Innovazione, Sperimentazione e Sviluppo, via Puglie 23, 00187 Rome (Italy) Corresponding author Antonio Migliore, MSc ([email protected]) Clinical experts Mario Alessiani, MD FACS Division of General Surgery, Varzi Hospital, University of Pavia (Italy) Marco Filauro, MD Division of General and Hepatobiliopancreatic Surgery, Galliera Hospital, Genova (Italy) Invited reviewers Chuong Ho, MD MSc Canadian Agency for Drugs and Technologies in Health (CADTH), Ottawa (Canada) Björn Fahlgren, MSc 2 Comité d’évaluation des technologies de santé (CEDIT), Paris (France) Acknowledgements Authors would like to thank Marina Cerbo (Agenas) and Simona Paone (Agenas), for the valuable help in reviewing the research protocol and the first draft of the report, Patrizia Brigoni (Agenas) for performing the systematic literature searches, Fabio Bernardini (Agenas) for his relevant support in retrieving the publications, and Laura Velardi (Agenas) for supporting consultation and analysis of databases. Declaration on the conflict of interest and privacy Authors, Clinical expert and External Reviewers declare that they do not receive benefits or harms from the publication of this report. None of the authors have or have held shares, consultancies or personal relationships with any of the producers of the devices assessed in this document. -
Fine Surgical Instruments for Research™
FINE SCIENCE TOOLS CATALOG 2021 FINE SCIENCE TOOLS CATALOG FINE SURGICAL INSTRUMENTS FOR RESEARCH™ TABLE OF CONTENTS | CATALOG 2021 Scissors 3 – 35 Spring 3 – 14 Fine 15 – 28 Letter from the Managing Partner Surgical 29 – 35 Bone Instruments 36 – 49 Rongeurs 36 – 38 Dear Customers, Cutters 39 – 47 Other Bone Instruments 47 – 48 After my uncle and founder of Fine Science Tools, Hans, handed Curettes & Chisels 49 over the management of the company to my cousin Rob and I Scalpels & Knives 50 – 61 last year, a lot has happened. Coming to FST as an “outsider”, my primary goal was to learn everything about the products, customers and the entire company. From my very first day, Forceps 63 – 91 I learned just how much my uncle Hans and the excellent Dumont 63 – 73 managerial team, Rob, Michael and Christina were able to Fine 72 – 80 grow the company over the last 45 years from a single office in Moria 74 S&T 75, 77 Vancouver into a global enterprise, a tremendous achievement Standard 81 – 91 that they should be proud of. Through excellent customer Hemostats 92 – 97 service, impeccable product quality and a passionate team, FST has become a household name in surgical and microsurgical instruments and accessories. During the COVID19 pandemic and the following worldwide lockdown, whether at their home office or on-site, our teams Probes & Hooks 99 – 103 around the world were able to provide our customers with the Spatulae 102 – 105 instruments and accessories they needed. Under challenging Hippocampal Tools & Spoons 106 – 107 circumstances, we kept our warehouses open in order to ship Pins & Holders 108 – 109 products to research laboratories, biotech’s and academic Wound Closure 110 – 121 institutions around the world while our support staff actively Needle Holders & Suture 110 – 118 Staplers, Clips & Applicators 119 – 121 continued to provide assistance to all customer questions and Retractors 122 – 129 inquiries. -
Product Catalogue Surgical Metal Instruments
Single-use Surgical Instruments PRODUCT CATALOGUE Table of Content AcXess Single Use Instruments and Application Sets Surgical Scissors 2 Dissecting Scissors 3 More Scissors 4 Forceps 6 Artery Forceps 7 Anatomic Artery Forceps 7 Surgical Tissue Forceps 9 Forceps 11 Anatomic Dissecting Forceps 11 Surgical Tissue Forceps 12 Needle holder 14 Retractors 15 Curettes 16 AcXess OR Sets 17 ProKit Application Sets 18 ProKit Suture Removal Sets 18 ProKit Care Sets for Wound Treatment 19 AcXess Stitch Alternatives 20 Surgical Stapler 20 Surgical Staple Remover 20 Product Overview AcXess SUORG Disposable Instruments for high demands o Complex, precise finishing o Special steel alloy o Funktionality and safety suitable for long interventions without loss of quality Instruments in SUORG quality are marked in light blue 1 AcXess Surgical Scissors Single-use surgical instruments Item no.: Characteristic Length SU* MI.22.111.130 sharp/sharp, straight 130 mm 20 pcs. MI.22.111.140 sharp/sharp, straight 140 mm 20 pcs. *: individual sterile packaging Item no.: Characteristic Length SU* MI.23.111.130 sharp/blunt, straight 130 mm 20 pcs. MI.23.111.140 sharp/blunt, straight 140 mm 20 pcs. *: individual sterile packaging Item no.: Characteristic Length SU* MI.24.111.130 blunt/blunt, straight 130 mm 20 pcs. MI.24.111.140 blunt/blunt, straight 140 mm 20 pcs. *: individual sterile packaging Item no.: Characteristic Length SU* MI.22.112.115 sharp/sharp, curved 115 mm 20 pcs. MI.22.112.130 sharp/sharp, curved 130 mm 20 pcs. MI.22.112.140 sharp/sharp, curved 140 mm 20 pcs. -
Keyword Index to Assist Manufacturers in Verifying the Class of Medical Devices
Therapeutic Products Programme Programme des produits thérapeutiques OUR MISSION: To ensure that the drugs, medical devices, NOTRE MISSION: Faire en sorte que les médicaments, lesmatériels and other therapeutic products available in Canada are safe, médicaux et les autres produits thérapeutiques disponibles au Canada effective and of high quality. soient sûrs, efficaces et de haute qualité. Therapeutic Products Programme Keyword Index To Assist Manufacturers In Verifying The Class of Medical Devices For more information please contact: Don Boyer Licensing Services Division Medical Devices Bureau 1605 Statistics Canada Main Building, Postal Locator: 0301H1 Tunney’s Pasture, Ottawa, Ontario K1A 0L2 phone: (613) 957-7090 fax: (613) 954-7666 e-mail: [email protected] Therapeutic Products Programme Medical Device Keyword Index DRAFT Introduction The Medical Device Keyword Index was prepared to assist manufacturers in verifying the device class for products after application of the Classification Rules for Medical Devices of the Medical Devices Regulations. The Index should also be used in conjunction with the guidance document “Guidance For The Risk Based Classification System, GD006/RevDR-MDB.” Please note that this document is provided as a guide and that in the event of any discrepancy between this guide and the Classification Rules for Medical Devices of the Medical Devices Regulations, the latter shall prevail. What is a Keyword Index? The Medical Device Keyword Index is an alphabetical listing of all the words which appear in all the short descriptors for all the device groups that have been identified by the Medical Devices Bureau. It contains synonyms and industry words that are commonly used to describe the products in these device groups. -
Biodegradable Surgical Staple Composed of Magnesium Alloy
www.nature.com/scientificreports OPEN Biodegradable Surgical Staple Composed of Magnesium Alloy Hizuru Amano 1, Kotaro Hanada2, Akinari Hinoki3, Takahisa Tainaka3, Chiyoe Shirota3, Wataru Sumida3, Kazuki Yokota3, Naruhiko Murase3, Kazuo Oshima3, Kosuke Chiba3, 3 3 Received: 11 February 2019 Yujiro Tanaka & Hiroo Uchida Accepted: 25 September 2019 Currently, surgical staples are composed of non–biodegradable titanium (Ti) that can cause allergic Published: xx xx xxxx reactions and interfere with imaging. This paper proposes a novel biodegradable magnesium (Mg) alloy staple and discusses analyses conducted to evaluate its safety and feasibility. Specifcally, fnite element analysis revealed that the proposed staple has a suitable stress distribution while stapling and maintaining closure. Further, an immersion test using artifcial intestinal juice produced satisfactory biodegradable behavior, mechanical durability, and biocompatibility in vitro. Hydrogen resulting from rapid corrosion of Mg was observed in small quantities only in the frst week of immersion, and most staples maintained their shapes until at least the fourth week. Further, the tensile force was maintained for more than a week and was reduced to approximately one-half by the fourth week. In addition, the Mg concentration of the intestinal artifcial juice was at a low cytotoxic level. In porcine intestinal anastomoses, the Mg alloy staples caused neither technical failure nor such complications as anastomotic leakage, hematoma, or adhesion. No necrosis or serious infammation reaction was histopathologically recognized. Thus, the proposed Mg alloy staple ofers a promising alternative to Ti alloy staples. Intestinal anastomosis using staples is widely practiced in surgery nowadays1–4. Staples used for this procedure are primarily composed of non–biodegradable titanium (Ti) alloy. -
Case Report Management of Total Transection of Nasoendotracheal Tube During Lefort I Osteotomy
Hindawi Case Reports in Anesthesiology Volume 2020, Article ID 2097240, 4 pages https://doi.org/10.1155/2020/2097240 Case Report Management of Total Transection of Nasoendotracheal Tube during LeFort I Osteotomy Miles Somers ,1 Peter Tsakiris,1 Peter Isert,2 and Samuel Kim 1 1Department of Oral and Maxillofacial Surgery, Prince of Wales Hospital, Randwick, NSW, Australia 2VMO Anaesthetist, Prince of Wales Private Hospital, Randwick, NSW, Australia Correspondence should be addressed to Miles Somers; [email protected] Received 10 March 2020; Revised 8 August 2020; Accepted 26 October 2020; Published 17 November 2020 Academic Editor: Pavel Michalek Copyright © 2020 Miles Somers et al. *is is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Transection of the nasoendotracheal tube during orthognathic surgery is a rare, but life-threatening complication. We present a case of complete nasoendotracheal tube transection during a LeFort 1 osteotomy and discuss appropriate preventative and management techniques. 1. Introduction 2. Case Report Complete transection of the nasoendotracheal tube (NET) A 28-year-old male underwent a 2-piece maxillary osteot- during surgery is rare [1]. However, it poses a potentially life- omy plus right ramus graft for genioplasty. *e aim of the threatening complication that must be managed effectively. surgery was orthognathic correction of a dentoskeletal class *ere are several reported cases in the literature reporting III malocclusion related to hypoplasia of the maxilla sec- both complete [2, 3] and partial transection [4–7]. Maxil- ondary to cleft lip and palate. -
Medical and Surgical Management, and Implications for the Practicing Gastroenterologist
UCSF UC San Francisco Previously Published Works Title Morbid obesity-the new pandemic: medical and surgical management, and implications for the practicing gastroenterologist. Permalink https://escholarship.org/uc/item/8pw8k8v6 Journal Clinical and translational gastroenterology, 4(6) ISSN 2155-384X Authors Cello, John P Rogers, Stanley J Publication Date 2013-06-06 DOI 10.1038/ctg.2013.6 Peer reviewed eScholarship.org Powered by the California Digital Library University of California Citation: Clinical and Translational Gastroenterology (2013) 4, e35; doi:10.1038/ctg.2013.6 & 2013 the American College of Gastroenterology All rights reserved 2155-384X/13 www.nature.com/ctg CLINICAL/NARRATIVE REVIEW Morbid Obesity—The New Pandemic: Medical and Surgical Management, and Implications for the Practicing Gastroenterologist John P. Cello, MD1 and Stanley J. Rogers, MD1 The gastroenterologist, whether in academic or clinical practice, must face the reality that an increasingly large percentage of adult patients are morbidly obese. Morbid obesity is associated with significant morbidity and mortality including enhanced morbidity from cardiovascular, cerebrovascular, hepatobiliary and colonic diseases. Most of these associated diseases are actually preventable. Based on the 1991 NIH consensus conference criteria, for most patients with a body mass index (BMI ¼ weight in kilograms divided by the height in meters squared) of 40 or more, or for patients with a BMI of 35 or more and significant health complications, surgery may be the only reliable option. Currently in the United States, over 250,000 bariatric surgical procedures are being performed annually. The practicing gastroenterologist in every community, large and small, must be familiar with the various surgical procedures together with their associated anatomic changes.